Results for tag: "Nucala"

Nucala is a biologic drug used to treat severe asthma in adults and children aged 12 and older. It is a monoclonal antibody that works by blocking the action of interleukin-5 (IL-5), a protein that plays a role in the inflammation associated with asthma. Nucala is administered as an injection under the skin or as an inhalation powder. It is typically used in combination with other asthma medications. Nucala is one of several biologic drugs used to treat severe asthma. Other biologics include Xolair, Cinqair, Fasenra, and Dupixent. These drugs are typically used in combination with other asthma medications, such as inhaled corticosteroids, long-acting beta agonists, and leukotriene modifiers. The companies in the Nucala market include GlaxoSmithKline, AstraZeneca, Sanofi, Regeneron, and Teva Pharmaceuticals. Show Less Read more